Literature DB >> 25537574

Correlation of lactate/albumin ratio level to organ failure and mortality in severe sepsis and septic shock.

Biao Wang1, Gang Chen2, Yifei Cao2, Jiping Xue2, Jia Li2, Yunfu Wu3.   

Abstract

BACKGROUND: This study examines the clinical utility of the increased lactate/albumin ratio as an indicator of multiple-organ dysfunction syndrome (MODS) and mortality in severe sepsis and septic shock.
METHODS: We designed a prospective cohort study in an intensive care unit, and 54 patients with severe sepsis or septic shock were included. Data were used to determine a relationship between lactate/albumin ratio and the development of MODS and mortality. These associations were determined by the Mann-Whitney test, multiple logistic regression, plotting the receiver operating characteristic curve and Spearman test.
RESULTS: Lactate/albumin ratio level was higher in MODS patients on day 1 (median [interquartile range, or IQR], 2.295 [1.818-3.065]; n = 30, P < .0001) than in those without (median [IQR], 1.550 (1.428-1.685); n = 24), and on day 2, (median [IQR], 1.810 [1.377-2.448]; n = 26, P = .0022) it was higher than in those without (median [IQR], 1.172 (1.129-1.382); n = 23) on day 2. We found that lactate/albumin ratio was an independent predictor of the development of MODS (odds ratio, 5.5; P = .033; 95% confidence interval, 1.1-26.1) during intensive care unit stay. The area under the receiver operating characteristic curve showed that lactate/albumin ratio could predict MODS (0.8458) and mortality (0.8449). Furthermore, the higher the Acute Physiology and Chronic Health Evaluation II score, the more lactate/albumin ratio was discovered on day 1 (r = 0.5315, P < .0001) and day 2 (r = 0.5408, P < .0001), whereas the lower partial pressure of oxygen in arterial blood/fraction of inspired oxygen ratio, the more lactate/albumin ratio was illustrated on day 1 (r = -0.5143, P < .0001) and day 2 (r = -0.5420, P < .0001).
CONCLUSIONS: Increased lactate/albumin ratio correlates with the development of MODS and mortality in patients with severe sepsis and septic shock.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Lactate/albumin ratio; MODS; Resuscitation; Severe sepsis and septic shock

Mesh:

Substances:

Year:  2014        PMID: 25537574     DOI: 10.1016/j.jcrc.2014.10.030

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  16 in total

1.  Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis.

Authors:  Bravein Amalakuhan; Sheila A Habib; Mandeep Mangat; Luis F Reyes; Alejandro H Rodriguez; Cecilia A Hinojosa; Nilam J Soni; Ryan P Gilley; Carlos A Bustamante; Antonio Anzueto; Stephanie M Levine; Jay I Peters; Stefano Aliberti; Oriol Sibila; James D Chalmers; Antoni Torres; Grant W Waterer; Ignacio Martin-Loeches; Jose Bordon; Jose Blanquer; Francisco Sanz; Pedro J Marcos; Jordi Rello; Julio Ramirez; Jordi Solé-Violán; Carlos M Luna; Charles Feldman; Martin Witzenrath; Richard G Wunderink; Daiana Stolz; Tim L Wiemken; Yuichiro Shindo; Charles S Dela Cruz; Carlos J Orihuela; Marcos I Restrepo
Journal:  Cytokine       Date:  2016-10-01       Impact factor: 3.861

2.  Lactate Albumin Ratio Is Associated With Mortality in Patients With Moderate to Severe Traumatic Brain Injury.

Authors:  Ruoran Wang; Min He; Fengyi Qu; Jing Zhang; Jianguo Xu
Journal:  Front Neurol       Date:  2022-04-01       Impact factor: 4.086

3.  APRIL and sTACI could be predictors of multiorgan dysfunction syndrome in sepsis.

Authors:  Dajana F Lendak; Dunja M Mihajlović; Aleksandra S Novakov-Mikić; Jasmina M Boban; Milan Ubavić; Snežana V Brkić
Journal:  Virulence       Date:  2018-12-31       Impact factor: 5.882

4.  Machine learning for the detection of early immunological markers as predictors of multi-organ dysfunction.

Authors:  Laura Bravo-Merodio; Animesh Acharjee; Jon Hazeldine; Conor Bentley; Mark Foster; Georgios V Gkoutos; Janet M Lord
Journal:  Sci Data       Date:  2019-12-19       Impact factor: 6.444

5.  The value of lactate/albumin ratio for predicting the clinical outcomes of critically ill patients with heart failure.

Authors:  Wenqin Guo; Lingyue Zhao; Hanjun Zhao; Fanfang Zeng; Changnong Peng; Wenyu Guo; Hongbing Yan
Journal:  Ann Transl Med       Date:  2021-01

6.  Prognostic value of the lactate/albumin ratio for predicting mortality in patients with pneumosepsis in intensive care units.

Authors:  Murat Erdoğan; Hüseyin Avni Findikli
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

7.  The Lactate/Albumin Ratio Predicts Mortality in Critically Ill Patients with Acute Kidney Injury: An Observational Multicenter Study on the eICU Database.

Authors:  Xu Zhu; Jing Xue; Zheng Liu; Wenjie Dai; Hui Xu; Qiaoling Zhou; Shuangping Zhao; Quan Zhou; Wenhang Chen
Journal:  Int J Gen Med       Date:  2021-12-30

8.  The Lactate/Albumin Ratio: A Valuable Tool for Risk Stratification in Septic Patients Admitted to ICU.

Authors:  Michael Lichtenauer; Bernhard Wernly; Bernhard Ohnewein; Marcus Franz; Bjoern Kabisch; Johanna Muessig; Maryna Masyuk; Alexander Lauten; Paul Christian Schulze; Uta C Hoppe; Malte Kelm; Christian Jung
Journal:  Int J Mol Sci       Date:  2017-09-02       Impact factor: 5.923

9.  Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification.

Authors:  Sarah McGarrity; Ósk Anuforo; Haraldur Halldórsson; Andreas Bergmann; Skarphéðinn Halldórsson; Sirus Palsson; Hanne H Henriksen; Pär Ingemar Johansson; Óttar Rolfsson
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

10.  Clinical Usefulness of Red Cell Distribution Width/Albumin Ratio to Discriminate 28-Day Mortality in Critically Ill Patients with Pneumonia Receiving Invasive Mechanical Ventilation, Compared with Lacate/Albumin Ratio: A Retrospective Cohort Study.

Authors:  Jong Hwan Jeong; Manbong Heo; Seung Jun Lee; Yi Yeong Jeong; Jong Deog Lee; Jung-Wan Yoo
Journal:  Diagnostics (Basel)       Date:  2021-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.